(E)-3-(4-Methoxyphenyl)-1-phenylprop-2-en-1-one, 95.0%, 5g

(2S,4S)-1-Boc-4-methyl-5-oxopyrrolidine-2-carboxylic acid ethyl ester, 97.0%, 250mg

bScope BS.1152-PLPHi for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Fivefold revolver E-plan Phase IOS 10/20/S40 S100x

N-Ethyl tadalafil, 98%, 10mg

Tantalum nitride powder 99.5% 10 g

METHYL 3-AMINO-2,6-DIFLUOROBENZOATE, 95.0%, 5g

(3-tert-Butyl-4-methoxyphenyl)boronic acid, 98%, 1g

O-(2,4-DICHLOROBENZYL)HYDROXYLAMINE HCL, 95.0%, 5g

(S)-2-(3-((1R,2R)-2-Aminocyclohexyl)thioureido)-N-benzyl-N,3,3-trimethylbutanamide, 98%, 250mg

N-tert-butyl-n-ethylnitrosamine, 97.0%, 5g

N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine, 10mg

1-Bromo-4-dodecylbenzene>90.0%(GC)25g

(1-methyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridin-3-yl)methanol dihydrochloride, 95.0%, 5g